Reilev, Mette
Lykkegaard, Jesper
Halling, Anders
Vestbo, Jørgen
Søndergaard, Jens
Pottegård, Anton
Article History
Received: 11 October 2016
Revised: 14 March 2017
Accepted: 21 March 2017
First Online: 17 April 2017
Competing interests
: Mette Reilev has received grants from The University of Southern Denmark and The Region of Southern Denmark related to the PhD, which this study is a part of. Jesper Lykkegaard has received Research grants from the governmental Region of Southern Denmark, the University of Southern Denmark, and the College of Danish General Practitioners and a research consultant fee from Boehringer-Ingelheim without relation to the submitted manuscript. Anders Halling declares no conflicts of interest. Jørgen Vestbo has received personal fees from AstraZeneca, Boehringer-Ingelheim, Chiesi, GlaxoSmithKline and Novartis, related to advising and presenting and all without relation to the submitted manuscript. Jens Søndergaard has been a member of the Scientific advisory Boards for AstraZeneca AB, GSK, and Boehringer-Ingelheim and has received funds from AstraZeneca and GSK, all without relation to the submitted manuscript. Anton Pottegård has received funds from AstraZeneca and Boehringer-Ingelheim for unrelated projects, paid to the institution where he was employed.